Yingwei Qi

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer
    Yingwei Qi
    Mayo Clinic Rochester, Rochester, Minnesota 55905, USA
    J Thorac Oncol 4:1075-82. 2009
  2. doi request reprint The purported effects of alcohol on appetite and weight in lung cancer patients
    Aminah Jatoi
    Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA
    Nutr Cancer 63:1251-5. 2011
  3. pmc Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer
    Yingwei Qi
    Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA
    Cancer 118:5358-65. 2012
  4. pmc Effect of cigarette smoking on quality of life in small cell lung cancer patients
    Jun Chen
    Department of Medical Oncology, The Second Affiliated Hospital, Dalian Medical University, 467 Zhongshan Road, ShaHeKou District, Dalian 116023, PR China
    Eur J Cancer 48:1593-601. 2012
  5. pmc Endpoints in phase II trials for advanced non-small cell lung cancer
    Sumithra J Mandrekar
    Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA
    J Thorac Oncol 5:3-9. 2010
  6. pmc Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials
    Nathan R Foster
    Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota
    Cancer 117:1262-71. 2011
  7. pmc Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer
    Aaron S Mansfield
    aDepartment of Medical Oncology, Mayo Clinic, Rochester, Minnesota bDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida cDepartment of Internal Medicine, Greater Baltimore Medical Center, Baltimore, Maryland dDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA
    Anticancer Drugs 24:1079-83. 2013
  8. pmc The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer
    Aminah Jatoi
    Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Support Care Cancer 18:1299-304. 2010

Collaborators

Detail Information

Publications8

  1. pmc Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer
    Yingwei Qi
    Mayo Clinic Rochester, Rochester, Minnesota 55905, USA
    J Thorac Oncol 4:1075-82. 2009
    ..We conducted this pooled analysis to assess the prognostic value of pretreatment Quality of Life (QOL) assessments on overall survival (OS) in advanced non-small cell lung cancer (NSCLC)...
  2. doi request reprint The purported effects of alcohol on appetite and weight in lung cancer patients
    Aminah Jatoi
    Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA
    Nutr Cancer 63:1251-5. 2011
    ..This report suggests a need for further study of alcohol as a palliative agent for cancer-associated loss of appetite and weight...
  3. pmc Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer
    Yingwei Qi
    Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA
    Cancer 118:5358-65. 2012
    ..Because progression-free survival (PFS)-based endpoints are controversial, the authors evaluated the impact of the progression date (PD) determination approach on PFS estimates...
  4. pmc Effect of cigarette smoking on quality of life in small cell lung cancer patients
    Jun Chen
    Department of Medical Oncology, The Second Affiliated Hospital, Dalian Medical University, 467 Zhongshan Road, ShaHeKou District, Dalian 116023, PR China
    Eur J Cancer 48:1593-601. 2012
    ..In this study, we sought to evaluate the relationship between cigarette smoking and QOL profiles in SCLC patients...
  5. pmc Endpoints in phase II trials for advanced non-small cell lung cancer
    Sumithra J Mandrekar
    Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA
    J Thorac Oncol 5:3-9. 2010
    ....
  6. pmc Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials
    Nathan R Foster
    Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota
    Cancer 117:1262-71. 2011
    ....
  7. pmc Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer
    Aaron S Mansfield
    aDepartment of Medical Oncology, Mayo Clinic, Rochester, Minnesota bDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida cDepartment of Internal Medicine, Greater Baltimore Medical Center, Baltimore, Maryland dDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA
    Anticancer Drugs 24:1079-83. 2013
    ..In summary, this phase I study was successful in identifying ATM 50 mg intramuscularly weekly as the MTD. Future clinical investigations targeting PKCι are currently in progress...
  8. pmc The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer
    Aminah Jatoi
    Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Support Care Cancer 18:1299-304. 2010
    ....